| Akcje insidera | 14 039 011 shares |
Wynik sentymentu insiderów
Ocena sentymentu insiderów pokazuje firmy, które są kupowane przez insiderów korporacyjnych.
Jest to wynik zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje spółki o najwyższym poziomie akumulacji informacji poufnych. Model rankingowy wykorzystuje kombinację liczby netto insiderów kupujących w ciągu ostatnich 90 dni, całkowitej liczby akcji kupionych jako procent akcji w obrocie oraz całkowitej liczby akcji posiadanych przez insiderów. Liczba ta waha się od 0 do 100, przy czym wyższe liczby wskazują na wyższy poziom akumulacji w porównaniu z innymi spółkami, a 50 to średnia.
Częstotliwość aktualizacji: codziennie
Ocena sentymentu kadry kierowniczej
Ocena sentymentu kadry kierowniczej pokazuje, że firmy są kupowane przez urzędników korporacyjnych.
Z definicji dyrektorzy korporacyjni to insiderzy korporacyjni, ale w przeciwieństwie do niektórych innych insiderów (10% akcjonariuszy i członków zarządu), dyrektorzy pracują dla firmy na co dzień i podczas handlu korzystają z własnych pieniędzy. (10% Akcjonariusze i członkowie zarządu często zarządzają funduszami zarządzających pieniędzmi innych osób). W związku z tym transakcje wykorzystujące informacje poufne dokonywane przez osoby z kadry kierowniczej mają znacznie większe znaczenie i powinny być odpowiednio traktowane.
Podobnie jak ocena sentymentu insiderów, ocena sentymentu kadry kierowniczej jest wynikiem zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje firmy o najwyższym poziomie akumulacji urzędników.
Częstotliwość aktualizacji: codziennie
Kluczowe wskaźniki insider
Ta karta pokazuje pozycję firmy według różnych wskaźników insider. Ranking według miary percentyla pokazuje, jak ta firma wypada na tle innych firm na rynkach amerykańskich. Wyższe rankingi wskazują na lepszą sytuację.
Na przykład ogólnie przyjmuje się, że kupowanie przez insiderów jest pozytywnym wskaźnikiem, zatem spółki z większą liczbą takich transakcji plasowałyby się wyżej niż spółki z mniejszą liczbą takich transakcji (lub nawet sprzedaży przez insiderów.
Liczba netto zakupów dokonanych przez insiderów (ranking)
N/A
Liczba netto zakupów dokonanych przez insiderów to łączna liczba insiderów kupujących pomniejszona o całkowitą liczbę insiderów sprzedających w ciągu ostatnich 90 dni. Tutaj pokazana jest miara percentyla (zakres od 0 do 100%).
Procent akcji kupowanych przez insiderów (ranking)
N/A
Procent akcji zakupionych przez insiderów to całkowita liczba akcji zakupionych przez insiderów pomniejszona o całkowitą liczbę akcji sprzedanych przez insiderów w ciągu ostatnich 90 dni, podzielona przez całkowitą liczbę akcji zakupionych przez insiderów i pomnożona przez 100.
Wykres handlu insider
Poniższy wykres przedstawia Ra Pharmaceuticals, Inc. transakcji zrealizowanych przez insiderów. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Ogólnie rzecz biorąc, dokonywanie transakcji w ich firmach przez osoby posiadające dostęp do informacji poufnych w oparciu o istotne, niepubliczne informacje jest generalnie nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4.
Lista insiderów i wskaźniki rentowności
Ta tabela przedstawia listę znanych insiderów i jest generowana automatycznie na podstawie zgłoszeń ujawnianych SEC. Oprócz nazwisk, najnowszego tytułu oraz oznaczenia dyrektora, członka kierownictwa lub 10% właściciela, podajemy najnowsze ujawnione pakiety akcji. Dodatkowo, jeśli to możliwe, udostępniamy historyczne wyniki handlowe danego insidera. Historyczne wyniki handlowe to średnia ważona wyników rzeczywistych transakcji zakupu na otwartym rynku dokonanych przez insiderów. Więcej informacji na temat sposobu obliczania tej wartości obejrzyj webinar na YouTube.
See our leaderboard of most profitable insider traders.
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|
Report errors via our new Insider Auditing Tool
Śledź historię zakupów insiderów — analiza zysków krótkoterminowych
W tej sekcji analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w RARX / Ra Pharmaceuticals, Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Śledź historię sprzedaży insider — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży insidera na otwartym rynku dokonanej w RARX / Ra Pharmaceuticals, Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia transakcji
Kliknij ikonę linku, aby zobaczyć pełną historię transakcji. Transakcje zgłoszone w ramach automatycznego planu handlowego 10b5-1 będą oznaczone znakiem X w kolumnie oznaczonej 10b-5.
| Plik Data |
Data transakcji |
Formularz | Wtajemniczony | Serce | Nazwa papieru wartościowego | Kod | Bezpośredni | Cena wykonania |
Cena jednostki |
Zmieniono jednostki |
Zmieniona wartość (1 tys.) |
Pozostałe opcje |
Pozostałe akcje |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-04-03 | 2020-04-02 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | -6 135 234 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Brennan Aoife | RARX | Stock Option (Right to Buy) | D | 16,36 | -25 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Brennan Aoife | RARX | Stock Option (Right to Buy) | D | 19,88 | -15 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Common Stock | I | 48,0000 | -4 858 260 | -233 196 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Heft Robert | RARX | Stock Option (Right to Buy) | D | 22,37 | -15 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Heft Robert | RARX | Stock Option (Right to Buy) | D | 19,88 | -15 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Heft Robert | RARX | Stock Option (Right to Buy) | D | 9,90 | -15 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Heft Robert | RARX | Stock Option (Right to Buy) | D | 2,87 | -22 857 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Shah Rajeev M. | RARX | Stock Option (Right to Buy) | D | 19,88 | -15 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Shah Rajeev M. | RARX | Stock Option (Right to Buy) | D | 22,37 | -15 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Shah Rajeev M. | RARX | Stock Option (Right to Buy) | D | 9,90 | -15 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 48,0000 | -4 858 260 | -233 196 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | King John C | RARX | Restricted Stock Units | D | -30 658 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | King John C | RARX | Stock Option (Right to Buy) | D | 21,00 | -107 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | King John C | RARX | Stock Option (Right to Buy) | D | 6,20 | -190 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | King John C | RARX | Common Stock | D | 48,0000 | -10 823 | -520 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | PEARSON TIMOTHY R | RARX | Stock Option (Right to Buy) | D | 22,37 | -15 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | PEARSON TIMOTHY R | RARX | Stock Option (Right to Buy) | D | 19,88 | -15 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | PEARSON TIMOTHY R | RARX | Stock Option (Right to Buy) | D | 9,90 | -15 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | PEARSON TIMOTHY R | RARX | Stock Option (Right to Buy) | D | 2,87 | -22 857 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Cumbo Alexander | RARX | Stock Option (Right to Buy) | D | 12,99 | -25 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Cumbo Alexander | RARX | Stock Option (Right to Buy) | D | 19,88 | -15 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Restricted Stock Units | D | -10 416 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 21,00 | -133 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 7,33 | -62 500 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 16,64 | -90 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 5,60 | -73 654 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 5,60 | -11 110 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Common Stock | D | 48,0000 | -14 492 | -696 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Restricted Stock Units | D | -9 166 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 21,00 | -107 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 7,33 | -55 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 16,64 | -67 500 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 5,60 | -25 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 2,87 | -26 422 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 2,87 | -46 434 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Common Stock | D | 48,0000 | -12 595 | -605 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Restricted Stock Units | D | -4 375 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 21,00 | -107 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 7,33 | -26 250 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 16,64 | -60 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 5,60 | -31 428 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 2,87 | -30 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 2,87 | -14 285 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 0,84 | -2 857 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Common Stock | D | 48,0000 | -2 973 | -143 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Restricted Stock Units | D | -10 416 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 21,00 | -133 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 7,33 | -62 500 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 16,64 | -112 500 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 5,60 | -28 571 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 2,87 | -92 283 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 2,87 | -115 572 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Common Stock | D | 48,0000 | -15 622 | -750 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Restricted Stock Units | D | -20 833 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 21,00 | -311 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 7,33 | -125 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 16,64 | -225 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 5,60 | -164 285 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 2,87 | -241 460 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 2,87 | -139 371 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Common Stock | D | 48,0000 | -234 707 | -11 266 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Mathers Edward T | RARX | Stock Option (Right to Buy) | D | 22,37 | -15 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Mathers Edward T | RARX | Stock Option (Right to Buy) | D | 19,88 | -15 000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Mathers Edward T | RARX | Stock Option (Right to Buy) | D | 9,90 | -15 000 | 0 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9 206 | 73 654 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1 389 | 11 110 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 45,1648 | -10 595 | -479 | 7 132 | ||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9 206 | 52 | 17 727 | ||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1 389 | 8 | 8 521 | ||||
| 2020-03-18 | 2020-03-17 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 44,2500 | -2 288 | -101 | 0 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9 206 | 82 860 | |||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1 389 | 12 499 | |||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 46,6116 | -10 595 | -494 | 7 132 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9 206 | 52 | 17 727 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1 389 | 8 | 8 521 | ||||
| 2020-01-21 | 2020-01-17 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 47,0200 | -2 285 | -107 | 2 288 | ||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9 206 | 92 066 | |||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1 389 | 13 888 | |||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 46,9505 | -10 595 | -497 | 7 132 | ||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9 206 | 52 | 17 727 | ||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1 389 | 8 | 8 521 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9 206 | 101 272 | |||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1 389 | 15 277 | |||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 47,2252 | -10 595 | -500 | 7 132 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9 206 | 52 | 17 727 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1 389 | 8 | 8 521 | ||||
| 2019-12-18 | 2019-12-17 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10 000 | 46 142 | |||||
| 2019-12-18 | 2019-12-17 | 4 | Read Simon | RARX | COMMON STOCK | D | 47,0821 | -10 000 | -471 | 6 234 | ||||
| 2019-12-18 | 2019-12-17 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10 000 | 29 | 16 234 | ||||
| 2019-12-18 | 2019-12-17 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 47,0759 | -2 285 | -108 | 4 573 | ||||
| 2019-11-18 | 2019-11-14 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10 000 | 56 142 | |||||
| 2019-11-18 | 2019-11-14 | 4 | Read Simon | RARX | COMMON STOCK | D | 46,6808 | -10 000 | -467 | 6 234 | ||||
| 2019-11-18 | 2019-11-14 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10 000 | 29 | 16 234 | ||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9 206 | 110 478 | |||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1 389 | 16 666 | |||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 46,6559 | -10 595 | -494 | 7 132 | ||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9 206 | 52 | 17 727 | ||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1 389 | 8 | 8 521 | ||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9 206 | 119 684 | |||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1 389 | 18 055 | |||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 46,8871 | -10 595 | -497 | 7 132 | ||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9 206 | 52 | 17 727 | ||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1 389 | 8 | 8 521 | ||||
| 2019-10-17 | 2019-10-16 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10 000 | 66 142 | |||||
| 2019-10-17 | 2019-10-16 | 4 | Read Simon | RARX | COMMON STOCK | D | 46,8726 | -10 000 | -469 | 6 234 | ||||
| 2019-10-17 | 2019-10-16 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10 000 | 29 | 16 234 | ||||
| 2019-10-17 | 2019-10-17 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 46,7000 | -2 285 | -107 | 6 858 | ||||
| 2019-09-16 | 2019-09-12 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10 000 | 76 142 | |||||
| 2019-09-16 | 2019-09-12 | 4 | Read Simon | RARX | COMMON STOCK | D | 25,4050 | -10 000 | -254 | 6 234 | ||||
| 2019-09-16 | 2019-09-12 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10 000 | 29 | 16 234 | ||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9 206 | 128 890 | |||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1 389 | 19 444 | |||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 25,2643 | -10 595 | -268 | 7 132 | ||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9 206 | 52 | 17 727 | ||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1 389 | 8 | 8 521 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 27,8949 | -2 285 | -64 | 9 143 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9 206 | 138 096 | |||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1 389 | 20 833 | |||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 27,7703 | -10 595 | -294 | 7 132 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9 206 | 52 | 17 727 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1 389 | 8 | 8 521 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10 000 | 86 142 | |||||
| 2019-08-27 | 2019-08-23 | 4 | Read Simon | RARX | COMMON STOCK | D | 27,7703 | -10 000 | -278 | 6 234 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10 000 | 29 | 16 234 | ||||
| 2019-07-18 | 2019-07-17 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10 000 | 96 142 | |||||
| 2019-07-18 | 2019-07-17 | 4 | Read Simon | RARX | COMMON STOCK | D | 32,9479 | -10 000 | -329 | 6 234 | ||||
| 2019-07-18 | 2019-07-17 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10 000 | 29 | 16 234 | ||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9 206 | 147 302 | |||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1 389 | 22 222 | |||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 33,2870 | -4 216 | -140 | 7 132 | ||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 32,9690 | -6 379 | -210 | 11 348 | ||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9 206 | 52 | 17 727 | ||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1 389 | 8 | 8 521 | ||||
| 2019-06-25 | 2019-06-21 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 23,7248 | -2 857 | -68 | 11 428 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9 206 | 156 508 | |||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1 389 | 23 611 | |||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 22,0439 | -7 184 | -158 | 7 132 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 21,4074 | -3 411 | -73 | 14 316 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9 206 | 52 | 17 727 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1 389 | 8 | 8 521 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10 000 | 106 142 | |||||
| 2019-06-19 | 2019-06-18 | 4 | Read Simon | RARX | COMMON STOCK | D | 23,0906 | -414 | -10 | 6 234 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Read Simon | RARX | COMMON STOCK | D | 22,2103 | -9 586 | -213 | 6 648 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10 000 | 29 | 16 234 | ||||
| 2019-06-13 | 2019-06-11 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Director Options to Purchase Common Stock (right to buy) | I | 19,88 | 15 000 | 15 000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Heft Robert | RARX | Option to Purchase Common Stock | D | 19,88 | 15 000 | 15 000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Brennan Aoife | RARX | Option to Purchase Common Stock | D | 19,88 | 15 000 | 15 000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | PEARSON TIMOTHY R | RARX | Option to Purchase Common Stock | D | 19,88 | 15 000 | 15 000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Cumbo Alexander | RARX | Option to Purchase Common Stock | D | 19,88 | 15 000 | 15 000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Shah Rajeev M. | RARX | Option to Purchase Common Stock | D | 19,88 | 15 000 | 15 000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Mathers Edward T | RARX | Option to Purchase Common Stock | D | 19,88 | 15 000 | 15 000 | |||||
| 2019-04-18 | 2019-04-16 | 4 | King John C | RARX | Restricted Stock Units | D | -15 329 | 30 658 | ||||||
| 2019-04-18 | 2019-04-16 | 4 | King John C | RARX | Common Stock | D | 21,9300 | -4 506 | -99 | 10 823 | ||||
| 2019-04-18 | 2019-04-16 | 4 | King John C | RARX | Common Stock | D | 15 329 | 15 329 | ||||||
| 2019-03-06 | 3 | Ricardo Alonso | RARX | Common Stock | D | 28 570 | ||||||||
| 2019-03-06 | 3 | Ricardo Alonso | RARX | Common Stock | D | 28 570 | ||||||||
| 2019-03-06 | 3 | Ricardo Alonso | RARX | Common Stock | D | 28 570 | ||||||||
| 2019-02-05 | 2019-02-01 | 4 | Treco Douglas A | RARX | Restricted Stock Units | D | -20 834 | 41 666 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Treco Douglas A | RARX | Options to Purchase Common Stock | D | 21,00 | 311 000 | 311 000 | |||||
| 2019-02-05 | 2019-02-01 | 4 | Treco Douglas A | RARX | COMMON STOCK | D | 21,0000 | -6 327 | -133 | 218 799 | ||||
| 2019-02-05 | 2019-02-01 | 4 | Treco Douglas A | RARX | COMMON STOCK | D | 20 834 | 225 126 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Farzaneh-Far Ramin | RARX | Restricted Stock Units | D | -10 417 | 20 833 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Farzaneh-Far Ramin | RARX | Options to Purchase Common Stock | D | 21,00 | 133 000 | 133 000 | |||||
| 2019-02-05 | 2019-02-01 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 21,0000 | -3 285 | -69 | 7 132 | ||||
| 2019-02-05 | 2019-02-01 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 10 417 | 10 417 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Read Simon | RARX | Restricted Stock Units | D | -9 167 | 18 333 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Read Simon | RARX | Options to Purchase Common Stock | D | 21,00 | 107 000 | 107 000 | |||||
| 2019-02-05 | 2019-02-01 | 4 | Read Simon | RARX | COMMON STOCK | D | 21,0000 | -2 933 | -62 | 6 234 | ||||
| 2019-02-05 | 2019-02-01 | 4 | Read Simon | RARX | COMMON STOCK | D | 9 167 | 9 167 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Lubner David Charles | RARX | Restricted Stock Units | D | -10 417 | 20 833 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Lubner David Charles | RARX | Options to Purchase Common Stock | D | 21,00 | 133 000 | 133 000 | |||||
| 2019-02-05 | 2019-02-01 | 4 | Lubner David Charles | RARX | COMMON STOCK | D | 21,0000 | -3 291 | -69 | 7 126 | ||||
| 2019-02-05 | 2019-02-01 | 4 | Lubner David Charles | RARX | COMMON STOCK | D | 10 417 | 10 417 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | King John C | RARX | Options to Purchase Common Stock | D | 21,00 | 107 000 | 107 000 | |||||
| 2018-12-14 | 2018-12-12 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Common Stock | I | 15,5000 | 1 006 452 | 15 600 | 4 858 260 | ||||
| 2018-12-14 | 2018-12-14 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 15,5000 | 645 161 | 10 000 | 6 135 234 | ||||
| 2018-12-14 | 2018-12-14 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 15,5000 | 1 006 452 | 15 600 | 4 858 260 | ||||
| 2018-11-15 | 2018-11-14 | 4 | Cumbo Alexander | RARX | Option to Purchase Common Stock | D | 12,99 | 25 000 | 25 000 | |||||
| 2018-11-01 | 2018-06-28 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Director Options to Purchase Common Stock (right to buy) | I | 9,90 | 15 000 | 15 000 | |||||
| 2018-09-25 | 2018-09-21 | 4 | Brennan Aoife | RARX | Options to Purchase Common Stock | D | 16,36 | 25 000 | 25 000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Director Options to Purchase Common Stock (right to buy) | I | 9,90 | 15 000 | 15 000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | Mathers Edward T | RARX | Options to Purchase Common Stock | D | 9,90 | 15 000 | 15 000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | Shah Rajeev M. | RARX | Options to Purchase Common Stock | D | 9,90 | 15 000 | 15 000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | Bisgaard Peter | RARX | Options to Purchase Common Stock | D | 9,90 | 15 000 | 15 000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | PEARSON TIMOTHY R | RARX | Options to Purchase Common Stock | D | 9,90 | 15 000 | 15 000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | Heft Robert | RARX | Options to Purchase Common Stock | D | 9,90 | 15 000 | 15 000 | |||||
| 2018-05-02 | 2018-05-01 | 4 | King John C | RARX | Restricted Stock Units | D | 45 987 | 45 987 | ||||||
| 2018-05-02 | 2018-05-01 | 4 | King John C | RARX | Option to Purchase Common Stock | D | 6,20 | 190 000 | 190 000 | |||||
| 2018-02-21 | 2018-02-16 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 6,0000 | 2 000 000 | 12 000 | 5 490 073 | ||||
| 2018-02-16 | 2018-02-14 | 4 | RA CAPITAL MANAGEMENT, LLC See Note | RARX | Common Stock | I | 6,0000 | 2 500 000 | 15 000 | 3 851 808 | ||||
| 2018-02-16 | 2018-02-14 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 6,0000 | 2 500 000 | 15 000 | 3 851 808 | ||||
| 2018-02-05 | 2018-02-01 | 4 | Treco Douglas A | RARX | Restricted Stock Units | D | 0,00 | 62 500 | 62 500 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Treco Douglas A | RARX | Options to Purchase Common Stock | D | 7,33 | 125 000 | 125 000 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Lubner David Charles | RARX | Restricted Stock Units | D | 0,00 | 31 250 | 31 250 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Lubner David Charles | RARX | Options to Purchase Common Stock | D | 7,33 | 62 500 | 62 500 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Read Simon | RARX | Restricted Stock Unit | D | 0,00 | 27 500 | 27 500 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Read Simon | RARX | Options to Purchase Common Stock | D | 7,33 | 55 000 | 55 000 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Farzaneh-Far Ramin | RARX | Restricted Stock Unit | D | 0,00 | 31 250 | 31 250 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Farzaneh-Far Ramin | RARX | Options to Purchase Common Stock | D | 7,33 | 62 500 | 62 500 | |||||
| 2017-10-30 | 2017-10-26 | 4 | Bisgaard Peter | RARX | Options to Purchase Common Stock | D | 22,37 | 15 000 | 15 000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | Lettmann Jason | RARX | Options to Purchase Common Stock | D | 22,37 | 15 000 | 15 000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | Mathers Edward T | RARX | Options to Purchase Common Stock | D | 22,37 | 15 000 | 15 000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | PEARSON TIMOTHY R | RARX | Options to Purchase Common Stock | D | 22,37 | 15 000 | 15 000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | Shah Rajeev M. | RARX | Options to Purchase Common Stock | D | 22,37 | 15 000 | 15 000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | Heft Robert | RARX | Options to Purchase Common Stock | D | 22,37 | 15 000 | 15 000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | RA CAPITAL MANAGEMENT, LLC See Footnotes | RARX | Director Options to Purchase Common Stock (right to buy) | I | 22,37 | 15 000 | 15 000 | |||||
| 2017-06-20 | 2017-06-19 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 22,0182 | -3 220 | -71 | 2 251 457 | ||||
| 2017-06-20 | 2017-06-16 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 21,2445 | -53 200 | -1 130 | 2 254 677 | ||||
| 2017-06-12 | 2017-06-08 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 22,0000 | -700 | -15 | 2 307 877 | ||||
| 2017-06-08 | 2017-06-07 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 22,1073 | -4 840 | -107 | 2 308 577 | ||||
| 2017-06-08 | 2017-06-06 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 22,9806 | -7 274 | -167 | 2 313 417 | ||||
| 2017-06-06 | 2017-06-05 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 23,1146 | -4 780 | -110 | 2 320 691 | ||||
| 2017-06-06 | 2017-06-02 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 23,4714 | -14 867 | -349 | 2 325 471 | ||||
| 2017-06-02 | 2017-06-01 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 23,8926 | -10 722 | -256 | 2 340 338 | ||||
| 2017-06-02 | 2017-05-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 23,9426 | -35 539 | -851 | 2 351 060 | ||||
| 2017-05-30 | 2017-05-26 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25,1448 | -5 300 | -133 | 2 386 599 | ||||
| 2017-05-30 | 2017-05-25 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25,0000 | -53 | -1 | 2 391 899 | ||||
| 2017-05-25 | 2017-05-24 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25,0051 | -17 451 | -436 | 2 391 952 | ||||
| 2017-05-22 | 2017-05-18 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25,4977 | -9 019 | -230 | 2 409 403 | ||||
| 2017-05-18 | 2017-05-17 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25,5126 | -22 534 | -575 | 2 418 422 | ||||
| 2017-05-18 | 2017-05-16 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 26,3296 | -20 081 | -529 | 2 440 956 | ||||
| 2017-05-02 | 2017-03-01 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 20,9126 | -7 778 | -163 | 2 461 037 | ||||
| 2017-05-02 | 2017-02-28 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 20,8577 | -7 847 | -164 | 2 468 815 | ||||
| 2017-05-02 | 2017-02-27 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 20,9582 | -57 844 | -1 212 | 2 476 662 | ||||
| 2017-05-02 | 2017-02-24 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 20,9336 | -5 398 | -113 | 2 534 506 | ||||
| 2017-05-02 | 2017-02-23 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 21,0362 | -4 999 | -105 | 2 539 904 | ||||
| 2017-05-02 | 2017-02-22 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 21,8553 | -749 | -16 | 2 544 903 | ||||
| 2017-02-03 | 2017-02-01 | 4 | Lubner David Charles | RARX | Options to Purchase Common Stock | D | 16,64 | 112 500 | 112 500 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Treco Douglas A | RARX | Options to Purchase Common Stock | D | 16,64 | 225 000 | 225 000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Farzaneh-Far Ramin | RARX | Options to Purchase Common Stock | D | 16,64 | 90 000 | 90 000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Read Simon | RARX | Options to Purchase Common Stock | D | 16,64 | 67 500 | 67 500 | |||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Series B-2 Preferred Stock | D | -860 438 | 0 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Series B-1 Preferred Stock | D | -924 970 | 0 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Common Stock | D | 13,0000 | 246 154 | 3 200 | 2 031 562 | ||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Common Stock | D | 860 438 | 1 785 408 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Common Stock | D | 924 970 | 924 970 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Series B-2 Preferred Stock | D | -3 402 729 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Series B-1 Preferred Stock | D | -3 657 932 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Series A Preferred Stock | D | -9 728 589 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Warrants to Purchase Common Stock | D | 0,07 | -62 914 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 13,0000 | 84 615 | 1 100 | 2 545 652 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 486 104 | 2 461 037 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 522 561 | 1 974 933 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 1 389 797 | 1 452 372 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 13,0000 | -339 | -4 | 62 575 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 0,0700 | 62 914 | 4 | 62 914 | ||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | RARX | Series B-2 Preferred Stock | I | -4 015 378 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | RARX | Series B-1 Preferred Stock | I | -4 316 531 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Common Stock | I | 13,0000 | 161 538 | 2 100 | 1 351 808 | ||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | RARX | Common Stock | I | 573 624 | 1 190 270 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | RARX | Common Stock | I | 616 646 | 616 646 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Series B-2 Preferred Stock | D | -4 362 472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Series B-1 Preferred Stock | D | -4 689 657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Series A Preferred Stock | D | -12 447 605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Warrants to Purchase Common Stock | D | 0,07 | -80 658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 13,0000 | 338 462 | 4 400 | 3 490 073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 623 210 | 3 151 611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 669 951 | 2 528 401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 1 778 227 | 1 858 450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 13,0000 | -435 | -6 | 80 223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 0,0700 | 80 658 | 6 | 80 658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Series B-2 Preferred Stock | I | -4 362 472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Series B-1 Preferred Stock | I | -4 689 657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Series A Preferred Stock | I | -12 447 605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80 658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 13,0000 | 338 462 | 4 400 | 3 490 073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 623 210 | 3 151 611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 669 951 | 2 528 401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 1 778 227 | 1 858 450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80 223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 0,0700 | 80 658 | 6 | 80 658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Series B-2 Preferred Stock | I | -4 362 472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Series B-1 Preferred Stock | I | -4 689 657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Series A Preferred Stock | I | -12 447 605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80 658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 13,0000 | 338 462 | 4 400 | 3 490 073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 623 210 | 3 151 611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 669 951 | 2 528 401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 1 778 227 | 1 858 450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80 223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 0,0700 | 80 658 | 6 | 80 658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Series B-2 Preferred Stock | I | -4 362 472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Series B-1 Preferred Stock | I | -4 689 657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Series A Preferred Stock | I | -12 447 605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80 658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 13,0000 | 338 462 | 4 400 | 3 490 073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 623 210 | 3 151 611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 669 951 | 2 528 401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 1 778 227 | 1 858 450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80 223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 0,0700 | 80 658 | 6 | 80 658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Series B-2 Preferred Stock | I | -4 362 472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Series B-1 Preferred Stock | I | -4 689 657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Series A Preferred Stock | I | -12 447 605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80 658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 13,0000 | 338 462 | 4 400 | 3 490 073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 623 210 | 3 151 611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 669 951 | 2 528 401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 1 778 227 | 1 858 450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80 223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 0,0700 | 80 658 | 6 | 80 658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Series B-2 Preferred Stock | I | -4 362 472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Series B-1 Preferred Stock | I | -4 689 657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Series A Preferred Stock | I | -12 447 605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80 658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 13,0000 | 338 462 | 4 400 | 3 490 073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 623 210 | 3 151 611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 669 951 | 2 528 401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 1 778 227 | 1 858 450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80 223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 0,0700 | 80 658 | 6 | 80 658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Series B-2 Preferred Stock | I | -4 362 472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Series B-1 Preferred Stock | I | -4 689 657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Series A Preferred Stock | I | -12 447 605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80 658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 13,0000 | 338 462 | 4 400 | 3 490 073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 623 210 | 3 151 611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 669 951 | 2 528 401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 1 778 227 | 1 858 450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80 223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 0,0700 | 80 658 | 6 | 80 658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Series B-2 Preferred Stock | I | -4 362 472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Series B-1 Preferred Stock | I | -4 689 657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Series A Preferred Stock | I | -12 447 605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80 658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 13,0000 | 338 462 | 4 400 | 3 490 073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 623 210 | 3 151 611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 669 951 | 2 528 401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 1 778 227 | 1 858 450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80 223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 0,0700 | 80 658 | 6 | 80 658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Series B-2 Preferred Stock | I | -4 362 472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Series B-1 Preferred Stock | I | -4 689 657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Series A Preferred Stock | I | -12 447 605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80 658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 13,0000 | 338 462 | 4 400 | 3 490 073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 623 210 | 3 151 611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 669 951 | 2 528 401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 1 778 227 | 1 858 450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80 223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 0,0700 | 80 658 | 6 | 80 658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Series B-2 Preferred Stock | I | -4 362 472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Series B-1 Preferred Stock | I | -4 689 657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Series A Preferred Stock | I | -12 447 605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80 658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 13,0000 | 338 462 | 4 400 | 3 490 073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 623 210 | 3 151 611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 669 951 | 2 528 401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 1 778 227 | 1 858 450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80 223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 0,0700 | 80 658 | 6 | 80 658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lubner David Charles | RARX | Options to Purchase Common Stock | D | 2,87 | 29 285 | 29 285 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. | RARX | Series B-2 Preferred Stock | I | -4 015 378 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. See footnotes | RARX | Series B-1 Preferred Stock | I | -4 316 531 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 13,0000 | 161 538 | 2 100 | 1 351 808 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 573 624 | 1 190 270 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. See footnotes | RARX | Common Stock | I | 616 646 | 616 646 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Series B-2 Preferred Stock | D | -3 408 439 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Series B-1 Preferred Stock | D | -3 664 071 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Series A Preferred Stock | D | -9 744 916 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Warrants to Purchase Common Stock | D | 0,07 | -63 019 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 13,0000 | 263 538 | 3 426 | 2 745 846 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 486 919 | 2 482 308 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 523 438 | 1 995 389 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 1 392 130 | 1 471 951 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 13,0000 | -340 | -4 | 79 821 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 0,0700 | 63 019 | 4 | 80 161 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-2 Preferred Stock | I | -481 503 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-1 Preferred Stock | I | -3 533 875 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-2 Preferred Stock | I | -517 617 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-1 Preferred Stock | I | -3 798 914 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-2 Preferred Stock | I | -3 408 439 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-1 Preferred Stock | I | -3 664 071 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series A Preferred Stock | I | -9 744 916 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Warrants to Purchase Common Stock | I | 0,07 | -63 019 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 13,0000 | 15 633 | 203 | 4 066 503 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 13,0000 | 114 752 | 1 492 | 4 050 870 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 13,0000 | 263 538 | 3 426 | 3 936 118 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 68 786 | 3 672 580 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 504 839 | 3 603 794 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 73 945 | 3 098 955 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 542 702 | 3 025 010 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 486 919 | 2 482 308 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 523 438 | 1 995 389 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 1 392 130 | 1 471 951 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 13,0000 | -340 | -4 | 79 821 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 0,0700 | 63 019 | 4 | 80 161 | ||||
| 2016-10-25 | 3 | Morgenthaler Management Partners IX, LLC | RARX | Common Stock | D | 34 284 | ||||||||
| 2016-10-25 | 3 | Morgenthaler Management Partners IX, LLC | RARX | Common Stock | D | 34 284 | ||||||||
| 2016-10-25 | 3 | Morgenthaler Management Partners IX, LLC | RARX | Common Stock | D | 34 284 | ||||||||
| 2016-10-25 | 3 | Treco Douglas A | RARX | Common Stock | D | 408 584 | ||||||||
| 2016-10-25 | 3 | Treco Douglas A | RARX | Common Stock | D | 408 584 | ||||||||
| 2016-10-25 | 3 | Lettmann Jason See footnotes | RARX | Common Stock | I | 34 284 | ||||||||
| 2016-10-25 | 3 | Lettmann Jason See footnotes | RARX | Common Stock | I | 34 284 |
P
Otwarty rynek lub prywatny zakup niepochodnych lub pochodnych papierów wartościowych
S
Otwarty rynek lub prywatna sprzedaż niepochodnych lub pochodnych papierów wartościowych
A
Grant, nagroda lub inne nabycie papierów wartościowych od spółki (np. opcja)
C
Konwersja instrumentu pochodnego
D
Sprzedaż lub przeniesienie papierów wartościowych z powrotem do spółki
F
Zapłata ceny wykonania lub zobowiązania podatkowego z wykorzystaniem części papierów wartościowych otrzymanych od spółki
G
Darowizna papierów wartościowych przez lub na rzecz insidera
K
Swapy kapitałowe i podobne transakcje zabezpieczające
M
Wykonanie lub konwersja pochodnego papieru wartościowego otrzymanego od spółki (takiego jak opcja)
V
Transakcja dobrowolnie zgłoszona na Formularzu 4
J
Inne (wraz z przypisem opisującym transakcję)
